Dr. Christopher W. Sandifer, DO
Hematology & Oncology (Hematology & Oncology Physician)
150 Bergen Street, Uh I-248
Newark, NJ 07103
Who else practices at this address →
Essex County includes primary care (34% of residents) and mental health (11% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- Rowan University School of Osteopathic Medicine (2020)
- Years since graduation
- 6
- In the NPI registry since
- 2020
Licensed in Connecticut since 2025, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2020Medical school: Rowan University School of Osteopathic Medicine
- 2020Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
CT license 83518 (first issued 2025; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Trinity Health of New England Provider Network Organization Inc (653 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $122 in total to this clinician.
| AbbVie Inc. | $99.99 |
|---|---|
| Pfizer Inc. | $22.16 |
| Education | $99.99 |
|---|---|
| Food and Beverage | $22.16 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. May 22, 2025 | Education VENCLEXTA · ONCOLOGY · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.